Panacea Product “GenUltimate TBG” Poised for June 6, 2019 Launch Decision Diagnostics Corp (DECN) vs Johnson & Johnson (JNJ) Litigation Update
LOS ANGELES, CA - May 29, 2019 - Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year old, diabetes-focused bio-technology R&D firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for the GenUltimate! ('Sunshine'